Laurie A. Miller - 17 Sep 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
SVP, Human Resources
Signature
/s/ Michelle Basil, attorney-in-fact for Ms. Miller
Issuer symbol
HAE
Transactions as of
17 Sep 2021
Net transactions value
$0
Form type
4
Filing time
21 Sep 2021, 21:20:13 UTC
Previous filing
21 Sep 2021
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +2,848 +39% 10,081 17 Sep 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Equity Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
F3 This includes unvested RSUs previously reported.